Icon

SOLODYN (nda050808)- (EQ 45MG BASE,EQ 90MG BASE,EQ 135MG BASE,EQ 65MG BASE,EQ 115MG BASE,EQ 105MG BASE,EQ 80MG BASE,EQ 55MG BASE)

MINOCYCLINE HYDROCHLORIDE BAUSCH
EQ 45MG BASE,EQ 90MG BASE,EQ 135MG BASE,EQ 65MG BASE,EQ 115MG BASE,EQ 105MG BASE,EQ 80MG BASE,EQ 55MG BASE
Yes No
2027-Mar-07 Expired
None None
None No
SOLODYN is a tetracycline-class drug indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older.
8 2 5
Total Other Developers 1
Drugs with Suitability No
EQ 45MG BASE ** ** - - -
EQ 90MG BASE ** ** - - -
EQ 135MG BASE ** ** - - 1
EQ 65MG BASE ** ** - - 2
EQ 115MG BASE ** ** - - -
EQ 105MG BASE ** ** - - 2
EQ 80MG BASE ** ** - - 2
EQ 55MG BASE ** ** - - 3
NDA Sales Available Total Generic Sales Available
No 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** *** ******* ******* *********** *-**, **, ***, **, **, **, **, ** & *-**, ****, ******* ****** ***** *****, ******, *****, ***** & *** ******, ***** (***) ***
****** ********* ** ***** ******* *********** ****-*, **** **. *-* *** *-*-*, ******* ******** **** ***** **, ****. ****, ******* ****, ****. ****, *********, ****** ******* ******, ***** (***) ***
****** ********* ****** *** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ***** **** *** ***** ************ ******* *********** **** **. ***/*, ***, ***/*, ***/* & ***/* ******* ****** ***** *****, *******, *****, ***** & *** ******, ***** (***) ***
****** ********* ** ***** ******* *********** **** **. **-*, ***** *-*, ***** ********** ****, *****, ********, *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.